Bristol Myers Squibb
Westampton, NJ, United States
Matt Colombo, PhD is Director, Evidence Strategy, Worldwide Medical, Immunology at Bristol Myers Squibb.
1144: Deucravacitinib in Plaque Psoriasis: Maintenance of Response over 3 Years
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.
